Functional disorders of the gastrointestinal tract: Cost effectiveness review

Best Practice and Research: Clinical Gastroenterology

Volumn 27, Issue 6, 2013, Pages 913-931

  Mapel, Douglas W ^a  

^a LOVELACE CLINIC FOUNDATION   (United States)

Author keywords

Cost benefit analysis; Functional gastrointestinal disorders; Gastrointestinal diseases; MeSH keywords; Outcome assessment; Rome; Utilization

Indexed keywords

ANTIDEPRESSANT AGENT; BARIUM; BOTULINUM TOXIN; CANNABIS; CARBON 13; CYCLOBENZAPRINE; GABAPENTIN; LACTULOSE; LAXATIVE; MACROGOL; NON PRESCRIPTION DRUG; OMEPRAZOLE; PANCREAS ENZYME; PEPPERMINT OIL; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTON PUMP INHIBITOR; RANITIDINE; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; AEROPHAGIA; ANORECTAL DISEASE; ARTICLE; BLOATING; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE CLASSIFICATION; DRUG COST; DYSPEPSIA; DYSPHAGIA; EPIGASTRIC PAIN; ERADICATION THERAPY; ERUCTATION; FECES INCONTINENCE; GALLBLADDER DISEASE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; LEVATOR ANI MUSCLE; MEDICAL SUBJECT HEADINGS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; ODDI SPHINCTER; POSTPRANDIAL DISTRESS SYNDROME; PROCTALGIA; PROCTALGIA FUGAX; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROME III CLASSIFICATION SYSTEM; RUMINATION; THORAX PAIN; UREA BREATH TEST; VOMITING;

EID: 84887195083     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2013.09.003     Document Type: Review

References (114)

1. D.A. Drossman The functional gastrointestinal disorders and the Rome III process Gastroenterology 130 2006 1377 1390
2. S.M. Schappert, and C.W. Burt Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02 Vital Health Stat Ser 13 159 2006 1 66 Data from the National Health Survey
3. W.G. Thompson The road to Rome Gastroenterology 130 2006 1552 1556
4. R. Fass, and G. Tougas Functional heartburn: the stimulus, the pain, and the brain Gut 51 2002 885 892 (Pubitemid 35408615)
5. J.P. Galmiche, R.E. Clouse, A. Balint, I.J. Cook, P.J. Kahrilas, and W.G. Paterson Functional esophageal disorders Gastroenterology 130 2006 1459 1465
6. J.P. Moraes-Filho Refractory gastroesophageal reflux disease Arq Gastroenterol 49 2012 296 301
7. M. Frazzoni, R. Conigliaro, V.G. Mirante, and G. Melotti The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn Neurogastroenterol Motil 24 2012 141 146
8. F. Zerbib, S. Bruley des Varannes, M. Simon, and J.P. Galmiche Functional heartburn: definition and management strategies Curr Gastroenterol Rep 14 2012 181 188
9. P.M. Boyce, N.J. Talley, C. Burke, and N.A. Koloski Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study Intern Med J 36 2006 28 36 (Pubitemid 43362544)
10. P.S. Chahal, and S.S. Rao Functional chest pain: nociception and visceral hyperalgesia J Clin Gastroenterol 39 5 Suppl. 3 2005 S204 S209 [discussion S10]
11. W.M. Wong, and R. Fass Noncardiac chest pain Curr Treat Options Gastroenterol 7 2004 273 278 (Pubitemid 39139776)
12. W. Wang, Y.H. Sun, Y.Y. Wang, Y.T. Wang, W. Wang, and Y.Q. Li Treatment of functional chest pain with antidepressants: a meta-analysis Pain Physician 15 2012 E131 E142
13. A.M. Borzecki, M.C. Pedrosa, and M.J. Prashker Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis Arch Intern Med 160 2000 844 852 (Pubitemid 30165246)
14. J.J. Ofman, I.M. Gralnek, J. Udani, M.B. Fennerty, and R. Fass The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain Am J Med 107 1999 219 227 (Pubitemid 29421587)
15. P. Leslie, P.N. Carding, and J.A. Wilson Investigation and management of chronic dysphagia Br Med J 326 2003 433 436 (Pubitemid 36246320)
16. M. Hoy, A. Domer, E.K. Plowman, R. Loch, and P. Belafsky Causes of dysphagia in a tertiary-care swallowing center Ann Otol Rhinol Laryngol 122 2013 335 338
17. A. Bansal, and P.J. Kahrilas Has high-resolution manometry changed the approach to esophageal motility disorders? Curr Opin Gastroenterol 26 2010 344 351
18. R.P. Harar, S. Kumar, M.A. Saeed, and D.J. Gatland Management of globus pharyngeus: review of 699 cases J Laryngol Otol 118 2004 522 527 (Pubitemid 39061785)
19. B.E. Lee, and G.H. Kim Globus pharyngeus: a review of its etiology, diagnosis and treatment World J Gastroenterol 18 2012 2462 2471
20. T. Wilkins, R.A. Gillies, A. Getz, D. Zimmerman, and L. Kang Nasolaryngoscopy in a family medicine clinic: indications, findings, and economics J Am Board Fam Med 23 2010 591 597
21. A. Alaani, S. Vengala, and M.N. Johnston The role of barium swallow in the management of the globus pharyngeus Eur Arch Otorhinolaryngol 264 2007 1095 1097 (Pubitemid 47106831)
22. D. Mapel, M. Roberts, A. Overhiser, and A. Mason The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States Helicobacter 18 2013 54 65
23. J. Tack, N.J. Talley, M. Camilleri, G. Holtmann, P. Hu, and J.R. Malagelada Functional gastroduodenal disorders Gastroenterology 130 2006 1466 1479
24. N.J. Talley, N. Phung, and J.S. Kalantar ABC of the upper gastrointestinal tract: indigestion: when is it functional? Br Med J 323 2001 1294 1297 (Pubitemid 33135164)
25. N.J. Talley American Gastroenterological Association medical position statement: evaluation of dyspepsia Gastroenterology 129 2005 1753 1755
26. B.E. Lacy, K.T. Weiser, A.T. Kennedy, M.D. Crowell, and N.J. Talley Functional dyspepsia: the economic impact to patients Aliment Pharmacol Ther 38 2013 170 177
27. K.P. Holmes, J.C. Fang, and B.R. Jackson Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern BMC Health Serv Res 10 2010 344
28. N. Chiba, S.J. Van Zanten, P. Sinclair, R.A. Ferguson, S. Escobedo, and E. Grace Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial Br Med J 324 2002 1012 1016 (Pubitemid 34457514)
29. B.C. Delaney, M. Qume, P. Moayyedi, R.F. Logan, A.C. Ford, and C. Elliott Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial) Br Med J 336 2008 651 654 (Pubitemid 351481235)
30. A.S. Raghunath, A.P. Hungin, J. Mason, and W. Jackson Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized controlled trial Aliment Pharmacol Ther 25 2007 585 592
31. N. Vakil, N. Talley, S.V. van Zanten, N. Flook, T. Persson, and E. Bjorck Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms Clin Gastroenterol Hepatol 7 2009 756 761
32. M. Ochi, K. Tominaga, F. Tanaka, T. Tanigawa, H. Yamagami, and K. Watanabe Clinical classification of subgroups according to the Rome III criteria cannot be used to distinguish the associated respective pathophysiology in Japanese patients with functional dyspepsia Intern Med 52 2013 1289 1293
33. A.J. Bredenoord, B.L. Weusten, D. Sifrim, R. Timmer, and A.J. Smout Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring Gut 53 2004 1561 1565 (Pubitemid 39434094)
34. D.K. Chitkara, A.J. Bredenoord, M.J. Rucker, and N.J. Talley Aerophagia in adults: a comparison with functional dyspepsia Aliment Pharmacol Ther 22 2005 855 858 (Pubitemid 41564365)
35. A.J. Bredenoord, and A.J. Smout Impaired health-related quality of life in patients with excessive supragastric belching Eur J Gastroenterol Hepatol 22 2010 1420 1423
36. N.J. Talley Functional nausea and vomiting Aust Fam Physician 36 2007 694 697
37. T.H. Evans, and L.R. Schiller Chronic vestibular dysfunction as an unappreciated cause of chronic nausea and vomiting Proc - Bayl Univ Med Cent 25 2012 214 217
38. E.M. Quigley, W.L. Hasler, and H.P. Parkman AGA technical review on nausea and vomiting Gastroenterology 120 2001 263 286 (Pubitemid 32061891)
39. P.J. Pasricha, R. Colvin, K. Yates, W.L. Hasler, T.L. Abell, and A. Unalp-Arida Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying Clin Gastroenterol Hepatol 9 2011 567 576
40. R.S. Choung, G.R. Locke 3rd, R.M. Lee, C.D. Schleck, A.R. Zinsmeister, and N.J. Talley Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males Neurogastroenterol Motil 24 2012 20 26
41. C. Prakash, A. Staiano, R.J. Rothbaum, and R.E. Clouse Similarities in cyclic vomiting syndrome across age groups Am J Gastroenterol 96 2001 684 688 (Pubitemid 32240715)
42. J. Tack, K. Blondeau, V. Boecxstaens, and N. Rommel Review article: the pathophysiology, differential diagnosis and management of rumination syndrome Aliment Pharmacol Ther 33 2011 782 788
43. N. Rommel, J. Tack, J. Arts, P. Caenepeel, R. Bisschops, and D. Sifrim Rumination or belching-regurgitation? Differential diagnosis using oesophageal impedance-manometry Neurogastroenterol Motil 22 2010 e97 104
44. G.F. Longstreth, W.G. Thompson, W.D. Chey, L.A. Houghton, F. Mearin, and R.C. Spiller Functional bowel disorders Gastroenterology 130 2006 1480 1491
45. Y.A. Saito, P. Schoenfeld, and G.R. Locke 3rd The epidemiology of irritable bowel syndrome in North America: a systematic review Am J Gastroenterol 97 2002 1910 1915
46. R. Spiller, Q. Aziz, F. Creed, A. Emmanuel, L. Houghton, and P. Hungin Guidelines on the irritable bowel syndrome: mechanisms and practical management Gut 56 2007 1770 1798 (Pubitemid 350206308)
47. R.E. Williams, C.L. Black, H.Y. Kim, E.B. Andrews, A.W. Mangel, and J.J. Buda Stability of irritable bowel syndrome using a Rome II-based classification Aliment Pharmacol Ther 23 2006 197 205 (Pubitemid 43381184)
48. S.J. Vanner, W.T. Depew, W.G. Paterson, L.R. DaCosta, A.G. Groll, and J.B. Simon Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome Am J Gastroenterol 94 1999 2912 2917 (Pubitemid 29482757)
49. B.D. Cash, and W.D. Chey Irritable bowel syndrome - an evidence-based approach to diagnosis Aliment Pharmacol Ther 19 2004 1235 1245 (Pubitemid 38859499)
50. B.M. Spiegel, M. Farid, E. Esrailian, J. Talley, and L. Chang Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts Am J Gastroenterol 105 2010 848 858
51. B.M. Spiegel, V.P. DeRosa, I.M. Gralnek, V. Wang, and G.S. Dulai Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis Gastroenterology 126 2004 1721 1732 (Pubitemid 38736337)
52. S.M. Mein, and U. Ladabaum Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis Aliment Pharmacol Ther 19 2004 1199 1210 (Pubitemid 38746263)
53. L. Mohseninejad, T. Feenstra, H.E. van der Horst, H. Woutersen-Koch, and E. Buskens Targeted screening for coeliac disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information Eur J Health Econ 2012 Nov 18 [Epub ahead of print]
54. R.E. Williams, C.L. Black, H.Y. Kim, E.B. Andrews, A.W. Mangel, and J.J. Buda Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome Aliment Pharmacol Ther 23 2006 1667 1675 (Pubitemid 43727477)
55. M. Schmulson, and L. Chang Review article: the treatment of functional abdominal bloating and distension Aliment Pharmacol Ther 33 2011 1071 1086
56. A.K. Tuteja, N.J. Talley, S.K. Joos, K.G. Tolman, and D.H. Hickam Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders Am J Gastroenterol 103 2008 1241 1248 (Pubitemid 351677968)
57. A. Lopez-Colombo, D. Morgan, D. Bravo-Gonzalez, A. Montiel-Jarquin, S. Mendez-Martinez, and M. Schmulson The epidemiology of functional gastrointestinal disorders in Mexico: a population-based study Gastroenterol Res Pract 2012 606174 10.1155/2012/606174 [Epub 2012 Mar 19]
58. C. Shekhar, P.J. Monaghan, J. Morris, B. Issa, P.J. Whorwell, and B. Keevil Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin Gastroenterology 2013 Jul 19 10.1053/j.gastro.2013.07.014 pii: S0016-5085(13)01042-1. [Epub ahead of print]
59. N.C. Suares, and A.C. Ford Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis Am J Gastroenterol 106 2011 1582 1591
60. J.F. Guest, J.P. Clegg, and M.T. Helter Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK Curr Med Res Opin 24 2008 1841 1852
61. A. Wald, and L. Sigurdsson Quality of life in children and adults with constipation Best Pract Res Clin Gastroenterol 25 2011 19 27
62. M.A. van Tilburg, O.S. Palsson, R.L. Levy, A.D. Feld, M.J. Turner, and D.A. Drossman Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO BMC Complement Altern Med 8 2008 Jul 24 46 10.1186/1472-6882-8-46
63. Y.F. Zhao, X.J. Guo, Z.S. Zhang, X.Q. Ma, R. Wang, and X.Y. Yan Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China PLoS One 7 8 2012 e43749 10.1371/journal.pone.0043749 [Epub 2012 Aug 24]
64. B. Moghimi-Dehkordi, M. Vahedi, M.A. Pourhoseingholi, B. Khoshkrood Mansoori, A. Safaee, and M. Habibi Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study J Dig Dis 12 2011 384 392
65. G. Juckett, and R. Trivedi Evaluation of chronic diarrhea Am Fam Physician 84 2011 1119 1126
66. M. Sorouri, M.A. Pourhoseingholi, M. Vahedi, A. Safaee, B. Moghimi-Dehkordi, and A. Pourhoseingholi Functional bowel disorders in Iranian population using Rome III criteria Saudi J Gastroenterol 16 2010 154 160
67. F.Y. Chang, P.H. Chen, T.C. Wu, W.H. Pan, H.Y. Chang, and S.J. Wu Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria Asia Pac J Clin Nutr 21 2012 594 600
68. D. Roshandel, M. Rezailashkajani, S. Shafaee, and M.R. Zali A cost analysis of functional bowel disorders in Iran Int J Colorectal Dis 22 2007 791 799 (Pubitemid 46863756)
69. R.E. Clouse, E.A. Mayer, Q. Aziz, D.A. Drossman, D.L. Dumitrascu, and H. Monnikes Functional abdominal pain syndrome Gastroenterology 130 2006 1492 1497
70. N.A. Koloski, N.J. Talley, and P.M. Boyce Epidemiology and health care seeking in the functional GI disorders: a population-based study Am J Gastroenterol 97 2002 2290 2299
71. P.J. Matthews, and Q. Aziz Functional abdominal pain Postgrad Med J 81 2005 448 455 (Pubitemid 41002584)
72. M. Grover When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain Curr Gastroenterol Rep 14 2012 290 296
73. J. Behar, E. Corazziari, M. Guelrud, W. Hogan, S. Sherman, and J. Toouli Functional gallbladder and sphincter of Oddi disorders Gastroenterology 130 2006 1498 1509
74. E. Corazziari, E.A. Shaffer, W.J. Hogan, S. Sherman, and J. Toouli Functional disorders of the biliary tract and pancreas Gut 45 Suppl. 2 1999 II48 II54
75. J.K. DiBaise, B.K. Richmond, H.H. Ziessman, G.T. Everson, R.D. Fanelli, and A. Maurer Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel Clin Gastroenterol Hepatol 9 2011 376 384
76. L. Yap, A.G. Wycherley, A.D. Morphett, and J. Toouli Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy Gastroenterology 101 1991 786 793
77. A. Rastogi, A. Slivka, A.J. Moser, and A. Wald Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain Dig Dis Sci 50 2005 1391 1401 (Pubitemid 41039184)
78. K. Bielefeldt Regional differences in hospitalizations and cholecystectomies for biliary dyskinesia J Neurogastroenterol Motil 19 2013 381 389
79. M. Dauer, and F. Lammert Mandatory and optional function tests for biliary disorders Best Pract Res Clin Gastroenterol 23 2009 441 451
80. S. Bjorck, L. Enochsson, and J. Svanvik Commentary: the rising tide of cholecystectomy for biliary dyskinesia Aliment Pharmacol Ther 37 2013 493 494
81. K. Bielefeldt The rising tide of cholecystectomy for biliary dyskinesia Aliment Pharmacol Ther 37 2013 98 106
82. S. Bar-Meir, Z. Halpern, E. Bardan, and T. Gilat Frequency of papillary dysfunction among cholecystectomized patients Hepatology 4 1984 328 330 (Pubitemid 14131444)
83. D.A. Drossman, Z. Li, E. Andruzzi, R.D. Temple, N.J. Talley, and W.G. Thompson U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact Dig Dis Sci 38 1993 1569 1580 (Pubitemid 23271409)
84. J.Q. Gong, J.D. Ren, F.Z. Tian, R. Jiang, L.J. Tang, and Y. Pang Management of patients with sphincter of Oddi dysfunction based on a new classification World J Gastroenterol 17 2011 385 390
85. A.G. Craig, and J. Toouli Sphincterotomy for biliary sphincter of Oddi dysfunction Cochrane Database Syst Rev 3 2001 CD001509
86. M.L. Freeman, M. Gill, C. Overby, and Y.Y. Cen Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of Oddi dysfunction J Clin Gastroenterol 41 2007 94 102 (Pubitemid 46045677)
87. E. Kalaitzakis, T. Ambrose, J. Phillips-Hughes, J. Collier, and R.W. Chapman Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry BMC Gastroenterol 10 2010 124
88. J. Toouli Sphincter of Oddi: function, dysfunction, and its management J Gastroenterol Hepatol 24 Suppl. 3 2009 S57 S62
89. T.C. Hall, A.R. Dennison, and G. Garcea The diagnosis and management of sphincter of Oddi dysfunction: a systematic review Langenbecks Arch Surg 397 2012 889 898
90. V. Vitton, S. Ezzedine, J.M. Gonzalez, M. Gasmi, J.C. Grimaud, and M. Barthet Medical treatment for sphincter of Oddi dysfunction: can it replace endoscopic sphincterotomy? World J Gastroenterol 18 2012 1610 1615
91. V. Durkalski, W. Stewart, P. MacDougall, P. Mauldin, J. Romagnuolo, and O. Brawman-Minzter Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction World J Gastroenterol 16 2010 4416 4421
92. W.E. Whitehead, A. Wald, N.E. Diamant, P. Enck, J.H. Pemberton, and S.S. Rao Functional disorders of the anus and rectum Gut 45 Suppl. 2 1999 II55 II59
93. A.E. Bharucha, A. Wald, P. Enck, and S. Rao Functional anorectal disorders Gastroenterology 130 2006 1510 1518
94. R.L. Nelson Epidemiology of fecal incontinence Gastroenterology 126 1 Suppl. 1 2004 S3 S7
95. W.E. Whitehead, L. Borrud, P.S. Goode, S. Meikle, E.R. Mueller, and A. Tuteja Fecal incontinence in US adults: epidemiology and risk factors Gastroenterology 137 2009 512 517
96. A.E. Bharucha, A.R. Zinsmeister, G.R. Locke, B.M. Seide, K. McKeon, and C.D. Schleck Prevalence and burden of fecal incontinence: a population-based study in women Gastroenterology 129 2005 42 49 (Pubitemid 41002041)
97. M. Halland, and N.J. Talley Fecal incontinence: mechanisms and management Curr Opin Gastroenterol 28 2012 57 62
98. M. Deutekom, A.C. Dobben, M.G. Dijkgraaf, M.P. Terra, J. Stoker, and P.M. Bossuyt Costs of outpatients with fecal incontinence Scand J Gastroenterol 40 2005 552 558 (Pubitemid 40676248)
99. G.C. Dunivan, S. Heymen, O.S. Palsson, M. von Korff, M.J. Turner, and J.L. Melville Fecal incontinence in primary care: prevalence, diagnosis, and health care utilization Am J Obstet Gynecol 202 2010 493e1 493e6
100. X. Xu, S.B. Menees, M.K. Zochowski, and D.E. Fenner Economic cost of fecal incontinence Dis Colon Rectum 55 2012 586 598
101. A.E. Bharucha Outcome measures for fecal incontinence: anorectal structure and function Gastroenterology 126 1 Suppl. 1 2004 S90 S98
102. H.S. Harvie, L.A. Arya, E.K. Saks, M.D. Sammel, J.S. Schwartz, and J.A. Shea Utility preference score measurement in women with fecal incontinence Am J Obstet Gynecol 204 2011 72e1 72e6
103. M. Indinnimeo, C. Ratto, C.M. Moschella, A. Fiore, M. Brosa, and S. Giardina Sacral neuromodulation for the treatment of fecal incontinence: analysis of cost-effectiveness Dis Colon Rectum 53 2010 1661 1669
104. A.M. Leroi, X. Lenne, B. Dervaux, E. Chartier-Kastler, B. Mauroy, and L.L. Normand Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinence Ann Surg 253 2011 720 732
105. F.W. Leung Treatment of fecal incontinence - review of observational studies (OS) and randomized controlled trials (RCT) related to injection of bulking agent into peri-anal tissue J Interv Gastroenterol 1 2011 202 206
106. A.E. Bharucha, and E. Trabuco Functional and chronic anorectal and pelvic pain disorders Gastroenterol Clin North Am 37 2008 685 696
107. G. Chiarioni, A. Nardo, I. Vantini, A. Romito, and W.E. Whitehead Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome Gastroenterology 138 2010 1321 1329
108. G. Chiarioni, C. Asteria, and W.E. Whitehead Chronic proctalgia and chronic pelvic pain syndromes: new etiologic insights and treatment options World J Gastroenterol 17 2011 4447 4455
109. M. Sheikh, C.A. Kunka, and K.S. Ota Treatment of levator ani syndrome with cyclobenzaprine Ann Pharmacother 46 10 2012 e29
110. S.S. Rao, J. Paulson, M. Mata, and B. Zimmerman Clinical trial: effects of botulinum toxin on levator ani syndrome - a double-blind, placebo-controlled study Aliment Pharmacol Ther 29 2009 985 991
111. W.G. Thompson Proctalgia fugax in patients with the irritable bowel, peptic ulcer, or inflammatory bowel disease Am J Gastroenterol 79 1984 450 452 (Pubitemid 14086666)
112. V.F. Eckardt, O. Dodt, G. Kanzler, and G. Bernhard Treatment of proctalgia fugax with salbutamol inhalation Am J Gastroenterol 91 1996 686 689 (Pubitemid 26117943)
113. S.S. Rao, and K. Meduri What is necessary to diagnose constipation? Best Pract Res Clin Gastroenterol 25 2011 127 140
114. J.E. Siegel, M.C. Weinstein, L.B. Russell, and M.R. Gold Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine J Am Med Assoc 276 1996 1339 1341 (Pubitemid 26346934)